Z-0443-2021 Class II Terminated
FDA device recall Z-0443-2021 was initiated by Maquet Cardiovascular Us Sales, Llc on Sep 30, 2020 and is designated Class II. Reason for recall: The Printed Circuit Board Assembly (PCBA) are not in compliance with the IEC standard (60601 1, third edition). The BMU 40 units affected by this recall were designed with a short creepage distance… The recall status is terminated (terminated May 25, 2023). Affected quantity: 51 units.
Recall details
- Product Type
- Devices
- Report Date
- Nov 18, 2020
- Initiation Date
- Sep 30, 2020
- Termination Date
- May 25, 2023
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 51 units
Product description
Reason for recall
Distribution pattern
Worldwide distribution - US Nationwide distribution including in the states of AZ, CA, IA, MD, NC, PA, TX, WA, WI and the countries of Australia, Belgium, Brazil, Canada, Chile, China, Czech Republic, Ecuador, Finland, France, Germany, Hong Kong, India, Iran, Iraq, Ireland, Italy, Jordan, Malaysia, Malta, Netherlands, Norway, Pakistan, Peru, Poland, Russia, Saudi Arabia, Singapore, South Africa, Spain, Sweden, Switzerland, Syria, Thailand, Turkey, United Arab Emirates, United Kingdom, Venezuela.
Code information
Source
- Dataset
- openFDA device recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for Z-0443-2021
- openFDA file date
- Nov 10, 2026
- Loaded by RegDataLab
- Nov 11, 2026